The GLIPR2 gene is located on chromosome 9 and is a protein-coding gene. The protein encoded by this gene is involved in several critical cellular functions, including protein homodimerization activity, positive regulation of the ERK1 and ERK2 cascade, and epithelial to mesenchymal transition (EMT) . The protein is primarily located in the Golgi membrane, which is essential for its function in cellular processes.
GLIPR2 plays a significant role in the regulation of epithelial cell migration and EMT. EMT is a process where epithelial cells lose their cell polarity and adhesion properties, gaining migratory and invasive characteristics typical of mesenchymal stem cells. This transition is crucial in various physiological and pathological processes, including embryogenesis, wound healing, and cancer metastasis .
GLIPR2 has been studied extensively for its role in cancer. It has been found to be upregulated in several types of cancer, including hepatocellular carcinoma and renal clear cell carcinoma (ccRCC). In ccRCC, GLIPR2 is associated with cellular metastasis and the infiltration of CD8+ T cells . High expression levels of GLIPR2 in ccRCC are correlated with an unfavorable prognosis, making it a potential predictive biomarker for metastasis, immune infiltration, and prognosis .
Recent studies have highlighted the potential of GLIPR2 as a target for immunotherapeutic interventions. The protein’s involvement in immune cell infiltration and its regulatory role in EMT make it a promising candidate for developing targeted therapies for cancer treatment . Further research is needed to fully understand the mechanisms by which GLIPR2 regulates these processes and to explore its potential in clinical applications.